May 17th 2024
Scassellati Sforzolini discusses the significance of Galderma’s nemolizumab receiving 4 additional filing acceptances for prurigo nodularis and atopic dermatitis.
Use of Virtual Reality in Dermatology Education Deemed Technically Feasible and Useful for Learning
March 22nd 2024Researchers developed a VR scenario skin cancer screening involving technical realization, curricular integration, and an evaluation of the subjective learning experience and teaching concept.